期刊文献+

HPLC-MS/MS法测定恒河猴血浆中地尔硫卓的质量浓度

Determination of diltiazem in rhesus monkey plasma by HPLC-MS /MS
原文传递
导出
摘要 目的建立恒河猴血浆中地尔硫卓质量浓度的HPLC-MS/MS测定方法。方法采用Agilent Zorbax SB-C18色谱柱(2.1 mm×100 mm,3.5μm),以乙腈-10 mmol·L^-1醋酸铵(体积比75∶25)为流动相,流速为0.3 mL·min-1,柱温30℃。血浆样品采用叔丁基甲醚沉淀蛋白法处理,质谱采用电喷雾离子源,正离子化检测,扫描方式为多离子反应监测(MRM)。结果地尔硫卓的线性范围为0.2~200.0μg·L^-1,r=0.995 8,日内、日间精密度RSD〈15%,平均提取回收率为70.5%~74.0%,基质效应符合相关规定。地尔硫卓在恒河猴体内主要药代动力学参数:t1/2为(4.06±0.64)h,ρmax为(95.68±13.39)μg·L^-1,AUC0-t为(746.09±45.14)μg·h·L^-1。结论该方法适用于地尔硫卓在恒河猴体内的血药质量浓度检测及药代动力学研究。 Objective To develop a high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method for the determination of diltiazem in rhesus monkey plasma. Methods The plasma samples were deproteinated with MTBE, and chromatographic separation was performed on an Agilent Zorb- ax SB-C18 column (2. 1 mm × 100 mm,3.5 μm). The mobile phase consisted of acetonitrile- 10 mmol.L^-1 CH3COONH4 ( V: V = 75:25 )at a flow rate of 0. 3 mL. min^- 1 and the column temperature was 30 ℃. A trip- quadrupole tandem mass spectrum with the electrospray ionization (ESI) source was applied and positive ion multiple reaction monitoring mode was operated. Results The method was linear over the range of 0. 2 - 200. 0 μg.L^-1 r =0. 995 8. The intra- and inter-day precision was within 15% in terms of relative standard deviation (RSD%). The average recoveries were between 70.5% -74.0% ,the matrix effects were up to the specification. Main pharmacokinetics parameters were as follows: t1/2 was (4. 06 ± 0.64) h,ρmax was (95.68 ± 13.39) μg.L^-1 ,AUC0-t was (746.09 ±45.14) μg.h.L^-1. Conclusions This simple and sensitive HPLC-MS/MS method is successfully applied to pharmacokinetic studies of diltiazem in rhesus monkeys.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2014年第6期483-487,共5页 Journal of Shenyang Pharmaceutical University
关键词 地尔硫卓 高效液相色谱-串联质谱 恒河猴 药代动力学 diltiazem HPLC-MS/MS rhesus monkey pharmacokinetics
  • 相关文献

参考文献11

  • 1CHAFFMAN M,BROGDEN R N. Diltiazem: a re- view of its pharmacological properties and therapeutic efficacy [ J ]. Drugs, 1985,29 ( 5 ) : 387 - 454.
  • 2施孝金,钟明康,王宏图,张静华.HPLC法同时测定人血浆中地尔硫卓及其代谢产物[J].药物分析杂志,1995,15(6):20-21. 被引量:4
  • 3董钰明,李春兰,张玲.高效液相色谱法同时测定人血清中美托洛尔、地尔硫卓及单硝酸异山梨酯[J].兰州大学学报(医学版),2010,36(4):48-51. 被引量:2
  • 4蒋娟娟,李一石,田蕾,黄一玲,成小如.控释和缓释地尔硫卓胶囊在健康人体的生物等效性[J].中国临床药理学杂志,2007,23(6):446-449. 被引量:3
  • 5代宗顺,顾世芬,侯淑贤,邵春丽,吴力,艾永循.口服单剂量地尔硫卓缓释胶囊的人体相对生物利用度研究[J].沈阳药科大学学报,2000,17(1):19-22. 被引量:4
  • 6DASANDI B, SHAH S, SHIVPRAKASH. Develop- ment and validation of a high throughput and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of diltiazem and its two me- tabolites in human plasma:Application to a bioequiva- lence study[J]. J Chromatogr B, 2009, 877 ( 1 ) : 791 - 798.
  • 7MOLDEN E, HELEN BφE G, CHRISTENSEN H, et al. High-performance liquid chromatography-mass spectrometry analysis of diltiazem and 11 of its phase I metabolites in human plasma[J]. J Pharm Biomed Anal,2003,33(2):275 -285.
  • 8LI Jia-li, WANG Xue-ding, WANG Chang-xi, et al. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liq- uid chromatography-tandem mass spectrometry:Appli- cation to a clinical drug-drug interaction study [J ]. J Chromatogr B ,2008,867 ( 1 ) : 111 - 118.
  • 9FU Qiang, KANG K W, HAN H K. Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-x-receptor activity and altered pharmacokinetics of diltiazem in rats[ J ]. Biopharm Drug Dispos ,2012,33 ( 8 ) :446 - 454.
  • 10LI Shui-jun ,LIU Gang-yi, JIA Jing-ying, et al. Simul- taneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatogra- phy-tandem mass spectrometry[J]. J Chromatogr B, 2007,847( 1 ) :174 - 181.

二级参考文献29

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部